Oliver Mühlemann

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 13

Top Venues

Nucleic acids research

The EMBO journal

RNA biology

PLoS pathogens

Universität Bern

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universität Bern

Switzerland

professor :: Chemistry & Biochemistry

Publications

Sofia Nasif, Martino Colombo, Anne-Christine Uldry, Markus S Schröder, Simone de Brot, Oliver Mühlemann
Inhibition of nonsense-mediated mRNA decay reduces the tumorigenicity of human fibrosarcoma cells. NAR cancer 5 (3) (2023)
Michal Domanski, Emil Dedic, Maria Escura Pérez, Antoine Cléry, Sébastien Campagne, Anne-Christine Uldry, Sophie Braga, Manfred Heller, Julius Rabl, Pavel Afanasyev, Daniel Boehringer, Jiri Novacek, Frédéric Hai-Trieu Allain, Oliver Mühlemann
40S hnRNP particles are a novel class of nuclear biomolecular condensates. Nucleic acids research 50 (11) (2022)
Lukas-Adrian Gurzeler, Jana Ziegelmüller, Oliver Mühlemann, Evangelos D Karousis
Production of human translation-competent lysates using dual centrifugation. RNA biology 19 (1) (2021)
Evangelos D Karousis, Foivos Gypas, Mihaela Zavolan, Oliver Mühlemann
Nanopore sequencing reveals endogenous NMD-targeted isoforms in human cells. Genome biology 22 (1) (2021)
Lara Contu, Giuseppe Balistreri, Michal Domanski, Anne-Christine Uldry, Oliver Mühlemann
Characterisation of the Semliki Forest Virus-host cell interactome reveals the viral capsid protein as an inhibitor of nonsense-mediated mRNA decay. PLoS pathogens 17 (5) (2021)
Soumasree De, Oliver Mühlemann
A comprehensive coverage insurance for cells: revealing links between ribosome collisions, stress responses and mRNA surveillance. RNA biology 19 (1) (2021)
Stefan Reber, Daniel Jutzi, Helen Lindsay, Anny Devoy, Jonas Mechtersheimer, Brunno Rocha Levone, Michal Domanski, Eva Bentmann, Dorothee Dormann, Oliver Mühlemann, Silvia M L Barabino, Marc-David Ruepp
The phase separation-dependent FUS interactome reveals nuclear and cytoplasmic function of liquid-liquid phase separation. Nucleic acids research 49 (13) (2021)
Yeonkyoung Park, Joori Park, Hyun Jung Hwang, Leehyeon Kim, Kwon Jeong, Hyun Kyu Song, Simone C Rufener, Oliver Mühlemann, Yoon Ki Kim
Translation mediated by the nuclear cap-binding complex is confined to the perinuclear region via a CTIF-DDX19B interaction. Nucleic acids research 49 (14) (2021)
Katharina Schubert, Evangelos D Karousis, Ahmad Jomaa, Alain Scaiola, Blanca Echeverria, Lukas-Adrian Gurzeler, Marc Leibundgut, Volker Thiel, Oliver Mühlemann, Nenad Ban
SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nature structural & molecular biology 27 (10) (2020)
Evangelos D Karousis, Lukas-Adrian Gurzeler, Giuditta Annibaldis, René Dreos, Oliver Mühlemann
Human NMD ensues independently of stable ribosome stalling. Nature communications 11 (1) (2020)
Pamela Nicholson, Asimina Gkratsou, Christoph Josi, Martino Colombo, Oliver Mühlemann
Dissecting the functions of SMG5, SMG7, and PNRC2 in nonsense-mediated mRNA decay of human cells. RNA (New York, N.Y.) 24 (4) (2018)
Oliver Mühlemann, Evangelos D Karousis
New functions in translation termination uncovered for NMD factor UPF3B. The EMBO journal 36 (20) (2017)
Stefan Reber, Jolanda Stettler, Giuseppe Filosa, Martino Colombo, Daniel Jutzi, Silvia C Lenzken, Christoph Schweingruber, Rémy Bruggmann, Angela Bachi, Silvia Ml Barabino, Oliver Mühlemann, Marc-David Ruepp
Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants. The EMBO journal 35 (14) (2016)

Oliver Mühlemann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Oliver Mühlemann